This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Alternating Hemiplegia of Childhood Foundation, Cure Ahc, Inc., Hope for Annabel. Active years: 2023.
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2023
Title: Neil Hackett: Innovator in Neurological Gene Therapy
Introduction
Neil Hackett is a prominent inventor based in Santa Monica, CA (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of neurological disorders. His innovative work focuses on the delivery of ATP1A3 genes to the central nervous system, which has the potential to transform therapeutic approaches for various neurological conditions.
Latest Patents
Neil Hackett holds 1 patent for his invention titled "AAV-mediated delivery of ATP1A3 genes to central nervous system." This invention relates to a transgenic vector designed for transducing cells of a mammal's central nervous system (CNS) and transgenically expressing a protein within the CNS. The transgenic vector comprises a virus-derived vector, a nucleic acid sequence encoding the protein, and an endogenous ATP1A3 promoter sequence. Additionally, the invention includes a composition featuring a recombinant AAV vector that contains a nucleic acid sequence encoding an ATP1A3 protein, suitable for administration into the CNS. Furthermore, it outlines methods for treating subjects with neurological disorders associated with mutations in the ATP1A3 gene and for delivering transgenic ATP1A3 DNA to the CNS of mammals.
Career Highlights
Throughout his career, Neil Hackett has worked with various organizations, including Hope for Annabel and Cure AHC, Inc. His expertise in gene therapy and dedication to advancing medical science have positioned him as a key figure in the field.
Collaborations
Neil has collaborated with notable individuals such as Simon Frost and Natalia Morsci. These partnerships have contributed to the development and refinement of his innovative approaches to gene therapy.
Conclusion
Neil Hackett's work in the field of neurological gene therapy exemplifies the impact of innovation on medical science. His contributions, particularly in the delivery of ATP1A3 genes, hold promise for improving treatments for neurological disorders.